Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older and have been diagnosed with pulmonary arterial hypertension (a specific type of high blood pressure affecting the lungs, classified as "Group 1" by the World Health Organization)
- You have been taking stable oral medication for your pulmonary arterial hypertension for at least four weeks before joining the trial
- You are able to take part in remote video or phone appointments (you have access to a phone or the internet)
- You are willing to sign a consent form agreeing to take part in the study
Who may not be able to join:
- You have severe memory, thinking, or mental health difficulties that might make it hard to follow the study's requirements
- You are unable to communicate by phone or video call for technical or personal reasons
- You are currently taking part in another clinical trial that involves a treatment or intervention
- You have a serious illness (unrelated to your lung condition) that means your life expectancy is less than 6 months
- You are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +55 11 2661-1548
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Medication Adherence (Martín-Bayarre-Grau Scale - MBG)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.